Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 368

    1.

    Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration.

    Calvo-González C, Reche-Frutos J, Donate-López J, García-Feijoó J, Leila M, Fernández-Pérez C, Garcia-Sánchez J.

    Br J Ophthalmol. 2008 Jan;92(1):74-5.PMID: 18156376 [PubMed - indexed for MEDLINE]Related articles

    2.

    Treatment of naïve lesions in neovascular age-related macular degeneration with pegaptanib.

    Quiram PA, Hassan TS, Williams GA.

    Retina. 2007 Sep;27(7):851-6.PMID: 17891008 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.

    Bashshur ZF, Schakal A, Hamam RN, El Haibi CP, Jaafar RF, Noureddin BN.

    Arch Ophthalmol. 2007 Oct;125(10):1357-61.PMID: 17923543 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

    Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

    5.
    6.

    Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

    Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

    Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.PMID: 18462575 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Single-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Ahadi H.

    Eur J Ophthalmol. 2008 Mar-Apr;18(2):297-300.PMID: 18320527 [PubMed - indexed for MEDLINE]Related articles

    8.

    12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.

    Retina. 2008 Feb;28(2):289-97.PMID: 18301052 [PubMed - indexed for MEDLINE]Related articles

    9.

    One-year follow-up of combined customized therapy. Photodynamic therapy and bevacizumab for exudative age-related macular degeneration.

    Navea A, Mataix J, Desco MC, Garcia-Pous M, Palacios E.

    Retina. 2009 Jan;29(1):13-9.PMID: 18854782 [PubMed - indexed for MEDLINE]Related articles

    10.

    Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

    BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

    Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evolving European guidance on the medical management of neovascular age related macular degeneration.

    Chakravarthy U, Soubrane G, Bandello F, Chong V, Creuzot-Garcher C, Dimitrakos SA 2nd, Korobelnik JF, Larsen M, Monés J, Pauleikhoff D, Pournaras CJ, Staurenghi G, Virgili G, Wolf S.

    Br J Ophthalmol. 2006 Sep;90(9):1188-96.PMID: 16929063 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Standardized visual acuity results associated with primary versus secondary bevacizumab (avastin) treatment for choroidal neovascularization in age-related macular degeneration.

    Falkenstein IA, Cheng L, Morrison VL, Kozak I, Tammewar AM, Freeman WR.

    Retina. 2007 Jul-Aug;27(6):701-6.PMID: 17621178 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    One-year results of photodynamic therapy for small predominantly classic choroidal neovascular membranes secondary to age-related macular degeneration.

    Doyle E, Khanwala M, Shah SP, Ong DG, Casswell AG.

    Eur J Ophthalmol. 2007 Sep-Oct;17(5):760-7.PMID: 17932852 [PubMed - indexed for MEDLINE]Related articles

    15.

    Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis.

    Parodi MB, Iacono P, Spasse S, Ravalico G.

    Am J Ophthalmol. 2006 Jan;141(1):123-8.PMID: 16386985 [PubMed - indexed for MEDLINE]Related articles

    16.

    Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results.

    Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR.

    Am J Ophthalmol. 2007 Dec;144(6):850-857. Epub 2007 Oct 22.PMID: 17949673 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib]

    Maier M, Feucht N, Huebner M, Lohmann C.

    Klin Monbl Augenheilkd. 2008 Jun;225(6):582-7. German. PMID: 18516780 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.

    Kourlas H, Abrams P.

    Clin Ther. 2007 Sep;29(9):1850-61. Review.PMID: 18035187 [PubMed - indexed for MEDLINE]Related articles

    20.

    Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.

    VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M.

    Ophthalmology. 2006 Sep;113(9):1508.e1-25. Epub 2006 Jul 7.PMID: 16828500 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data